JP Morgan raises Clicks stake to 5.47% amid 34% year-to-date share price decline

JP Morgan Chase & Co. (JP Morgan), the world’s largest bank by market capitalization, has raised its stake in South Africa’s Clicks Group, a leading retail and healthcare company led by Bertina Engelbrecht to 5.47%, even as the company’s share price declined by 34% year-to-date. 

The move comes as shares dropped from R33.13 in January to R21.9, reflecting sustained pressure on the healthcare retail giant’s stock.

The increase from 5.07% to 5.47%, disclosed in a regulatory filing dated July 30, 2026, represents an additional 0.4 percentage-point investment by the U.S. banking giant. Despite the sharp decline in Clicks’ share price, JP Morgan’s move signals continued institutional confidence in the company’s long-term growth prospects.\

JP Morgan increases stake in Clicks

JP Morgan’s expanded holding is now valued at approximately R2.75 billion (about $166 million), reinforcing its position as the second-largest shareholder in Clicks Group, behind South Africa’s Public Investment Corporation.

The investment highlights growing global interest in South Africa’s healthcare retail sector, where Clicks remains a dominant player. The company operates 936 stores and 720 in-store pharmacies, making it one of the largest pharmacy-led retail chains in the region.

Clicks shares decline amid market pressure

Clicks Group’s stock has faced sustained downward pressure in 2026, declining more than 34% year-to-date. The drop reflects broader market dynamics, including consumer spending constraints and sector-specific headwinds.

However, analysts often view increased institutional buying during a downturn as a signal of long-term value recognition, particularly in fundamentally strong companies.

Strong financial performance supports investor confidence

Despite the share price decline, Clicks Group continues to deliver solid financial results. In the first half of 2026, the company reported revenue of R26.74 billion, representing a 7.64% increase compared to the previous period.

Profit rose by 6.6% to R1.53 billion, while total assets climbed 11.1% to R23 billion, underscoring the company’s strong balance sheet and operational resilience.

Clicks Pharmacy remains a key growth driver, contributing significantly to revenue and reinforcing the group’s leadership in South Africa’s health, wellness, and beauty retail market.

Strategic bet on long-term growth

JP Morgan’s increased stake reflects a broader strategy to deepen exposure to resilient, consumer-driven sectors in emerging markets. By expanding its position in Clicks, the bank is aligning with a market leader that continues to demonstrate stability, scale, and consistent performance.

The move also underscores confidence in Clicks Group CEO Bertina Engelbrecht, under whose leadership the company has strengthened its market position and expanded its footprint across South Africa.

As market volatility persists, JP Morgan’s investment signals that global capital remains attracted to high-quality African retail assets with strong fundamentals and long-term growth potential.